MedTech Dive July 20, 2021
- After a sluggish first quarter, investment in medical device makers roared back in April through June to hit $8.2 billion, with early-stage startups among the biggest beneficiaries, according to a new report from CB Insights, whose research focuses on equity rounds to private healthcare companies.
- Late-stage funding kept pace with the prior quarter: Robot manufacturer CMR Surgical’s $600 million round and portable dialysis system maker Quanta Dialysis Technologies’ $245 million Series D deal led the category.
- Diabetes tech developers Fractyl Health and CeQur and pathology software startups CellsVision, Aiforia and PathAI also garnered fresh backing from investors.
The global healthcare sector attracted equity investment throughout the pandemic, and it is still pouring in. The...